High Accuracy of Recombinant Fusion Protein Early Secretory Antigenic Target Protein 6‐culture Filtrate Protein 10 Skin Test for the Detection of Tuberculosis Infection: a Phase III, Multi‐centered, Double‐blind, Hospital‐based, Randomized Controlled Trial
Lu Xia,Miao Xu,Feng Li,Tao Li,Heng Yang,Weihua Wang,Qi Wu,Youlun Li,Xiaohong Chen,Qinfang Ou,Naihui Chu,Hongqiu Pan,Qunyi Deng,Xiaodong Mei,Douglas B. Lowrie,Xuhui Liu,Guozhi Wang,Shuihua Lu
DOI: https://doi.org/10.1016/j.ijid.2022.11.014
IF: 12.073
2022-01-01
International Journal of Infectious Diseases
Abstract:Objectives: To verify the diagnostic utility of recombinant fusion protein ESAT6-CPF10 (EC), a novel skin test reagent to detect Mycobacterium tuberculosis infection. Methods: A multi-centered, double-blind, randomized controlled trial was conducted from December 17, 2015, to March 2, 2018. Participants involved in this study included those with active tuberculosis (TB), suspected pulmonary TB, or non-TB pulmonary disease. Each participant received three tests simultane-ously, TB-specific enzyme-linked immunospot assay (T-SPOT.TB), tuberculin skin test (TST), and EC skin test (ECST), and adverse events were reported. Results: Diagnostic accuracy was analyzed using data from 1085 protocol-compliant participants. The sen-sitivities of the ECST, TST, and T-SPOT.TB were 91.2% (95% CI, 89.0-93.2%), 91.4% (95% CI, 89.1-93.3%), and 92.1% (95% CI, 89.9-93.9%), respectively. The specificities of the ECST (69.7%, 95% CI, 64.5-74.5%) and T-SPOT.TB (76.1%, 95% CI, 71.2-80.5%) were significantly higher than the TST (54.4%, 95% CI, 48.9-59.7%). The agreements between ECST and TST (kappa = 0.632) and between ECST and T-SPOT.TB (kappa = 0.780) were substantial. No severe adverse event was reported. Conclusion: The diagnostic performance of the ECST was close to the T-SPOT.TB assay in the detection of TB infection and indicated good potential for clinical application in common scenarios. & COPY; 2022 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ )